ArticleBJGP open2023
GPs' experiences of phosphatidylethanol in treatment of hypertension: a qualitative study.
Article in BJGP open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 17 citations in OpenAlex.
- Implementing pragmatic case finding to address alcohol use in general practice: a mixed methods feasibility study.Scandinavian journal of primary health care · 2026Trial
- The global epidemiology of alcohol-associated liver disease.Hepatology communications · 2026Review
- Hypertension and alcohol: a cross-sectional study comparing PEth with AUDIT and AUDIT-C in primary care.Family practice · 2025Observational
- Task sharing and teamwork: clinician preferences for alcohol screening and brief interventions in cardiology.BMC research notes · 2025Article
- Predictors of alcohol use disorder in patients with hypertension: a national registry-based cohort study.BMC public health · 2025Article
- B-phosphatidylethanol testing to identify hazardous alcohol use in primary health care-a game changer and a challenge for general practitioners: a qualitative study.Scandinavian journal of primary health care · 2025Article
- Article
- Alcohol use as a modifiable risk factor in cardiology: A qualitative study of patient perspectives in Sweden.PloS one · 2025Article
- Comparing the Documentation of Phosphatidylethanol and Alcohol History in Hypertension Management in Primary Care: A Cross-Sectional Study.Journal of primary care & community healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHazardous alcohol use increases the risk of hypertension but is underdetected in primary healthcare (PHC) patients. Use of the biomarker phosphatidylethanol (PEth), which reflects the last 2-3 weeks of alcohol consumption, is increasing in Swedish PHC, but studies exploring its use for hypertension are scarce or missing.
aimTo explore GPs' experiences of using PEth to identify hazardous alcohol use in the context of managing hypertension. DESIGN &
settingA qualitative study of GPs (
methodThe GPs participated in five focus group interviews. A questioning route was used. The interviews were audio-recorded, transcribed verbatim, and analysed with inductive qualitative content analysis.
results
conclusionPEth is a useful tool that changed GPs' routines for addressing alcohol and identifying hazardous alcohol use in patients with hypertension managed in PHC. The GPs advocated adopting PEth as a routine test in the treatment of hypertension. However, PEth needs to be used with care to maximise benefit and minimise harm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.